Matthieu Perrenoud

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


12 publications

2023 | 2021 | 2020 | 2018 | 2017 |
2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
Altomare D., Barkhof F., Caprioglio C., Collij L.E., Scheltens P., Lopes Alves I., Bouwman F., Berkhof J., van Maurik I.S., Garibotto V. et al., 2023/06/01. JAMA neurology, 80 (6) pp. 548-557. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91DA519742CB]
Troubles cognitifs dans la sclérose en plaques : quand y penser ? [Cognitive impairment in multiple sclerosis: when to think about it?]
Perrenoud M., Blosch L., Du Pasquier R., Pot C., 2023/04/26. Revue medicale suisse, 19 (824) pp. 791-793. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9A05F4407CED]
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline.
Caprioglio C., Ribaldi F., Visser LNC, Minguillon C., Collij L.E., Grau-Rivera O., Zeyen P., Molinuevo J.L., Gispert J.D., Garibotto V. et al., 2023/01/03. JAMA network open, 6 (1) pp. e2250921. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9E4B633524A8]
2021
 
Unusual brainstem and spine involvement in post-transplant lymphoproliferative disease.
Vicino A., Perrenoud M.P., Yersin E., Dunet V., Théaudin M., 2021/12. Revue neurologique, 177 (10) pp. 1303-1305. Peer-reviewed.
[DOI][Pmid][serval:BIB_A721637F4A92]
 
Assessing neurophobia: A good move.
Perrenoud M., 2021/02/15. Journal of the neurological sciences, 421 p. 117323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F65DF25147ED]
2020
 
Teleneuropsychology: New technologies and assessment tools
Genoud-Prachex Thomas, Perrenoud Matthieu Paul, Brioschi Guevara Andrea, Bieler-Aeschlimann Mélanie, Moser Charlène, rouaud Olivier, Démonet jean-François, 2020/10/01. Revue de neuropsychologie.
[serval:BIB_AD31D42874CD]
 
Tele-neuropsychology, older patients and Covid-19 pandemic
Genoud-Prachex Thomas, Perrenoud Matthieu Paul, Brioschi Guevara andrea, Moser Charlène, Bieler-Aeschlimann Mélanie, Rouaud Olivier, Démonet jean-François, 2020/04/01. Revue de neuropsychologie.
[serval:BIB_9028547392D4]
Neurologie [Neurology 2019]
Perrenoud M., Pantazou V., Michel P., Hirt L., Ryvlin P., Theaudin M., Rouaud O., Benninger D., Novy J., Rossetti A.O. et al., 2020/01/15. Revue medicale suisse, 16 (676-7) pp. 68-71. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B367290289EE]
2018
Levetiracetam circulating concentrations and response in status epilepticus.
Perrenoud M., André P., Buclin T., Decosterd L.A., Rossetti A.O., Novy J., 2018/11. Epilepsy & behavior, 88 pp. 61-65. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4F4192BBC5DD]
2017
Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes.
van Coevorden-Hameete M.H., van Beuningen SFB, Perrenoud M., Will L.M., Hulsenboom E., Demonet J.F., Sabater L., Kros J.M., Verschuuren JJGM, Titulaer M.J. et al., 2017/09. Annals of clinical and translational neurology, 4 (9) pp. 680-686. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DE765C4A014F]
Intravenous lacosamide in status epilepticus: Correlation between loading dose, serum levels, and clinical response.
Perrenoud M., André P., Alvarez V., Stähli C., Decosterd L.A., Rossetti A.O., Novy J., 2017. Epilepsy Research, 135 pp. 38-42. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4B7DEF70D1C9]
 
Novel Treatment and New Drugs in Epilepsy Treatment.
Eskioglou E., Perrenoud M.P., Ryvlin P., Novy J., 2017. Current pharmaceutical design, 23 (42) pp. 6389-6398. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_77E71FE92990]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University